The public remains mostly ignorant of advances in radiotherapy, a survey showed today.
Even proton beam therapy – which has had massive recent media coverage – only struck a chord with 30% of people in a survey commissioned by Cancer Research UK.
In some cases survey participants were more likely to claim knowledge of a bogus therapy – "Higgs-Boson radiotherapy" – than some of the latest treatments.
Some 6% claimed to have heard of the Higgs-Boson treatment while just 4% claimed knowledge of intensity-modulated radiotherapy (IMRT).
Just 3% claimed to have heard of stereotactic ablative radiotherapy – and 9% to have heard of image-guided radiotherapy.
Cancer Research UK said the findings were reflected in the relative priority respondents gave to radiotherapy against investment in chemotherapy. Some 57% said drug treatments should take priority for funding while just 9% said radiotherapy should take priority.
The survey of some 2,081 people was conducted by on-line pollsters YouGov.
The chair of the Radiotherapy Awareness Programme, Diana Tait, said: “We were shocked that only nine per cent of people think radiotherapy should be the highest priority for NHS funding into cancer treatments.
“Patients don’t always get the most advanced form of radiotherapy that could give them the best chance. This isn’t acceptable.
“We want to raise awareness of how advanced radiotherapy is a better, kinder treatment, so that all patients who need it can get it on the NHS.”
* Proton beam therapy hit the headlines last year when a family took their five-year-old child out of an NHS hospital so he could get the treatment in Prague. The family of Ashya King were the subject of a police hunt, which led to Spain.
* A second awareness campaign is to be launched next week to improve awareness of haematological malignancies.
The campaign is being launched by charity Bloodwise, formerly Leukaemia & Lymphoma Research.
A survey by the charity found that just 38% of people had heard of myeloma – and many confused it with melanoma.
It said that lack of awareness contributes to the stress, uncertainty and worry that newly-diagnosed patients face.
Diana Jupp, from Bloodwise, said: "Patients have told us that a lack of awareness has a significant impact throughout their patient journey – from confusion and uncertainty at diagnosis to being unaware of the organisations that provide the support and care they need.”

Leave a Reply